Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography Comparison with monkey and rat brain

[1]  S. Jin,et al.  Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Page,et al.  Phosphodiesterases: the journey towards therapeutics. , 2000, Trends in pharmacological sciences.

[3]  J. Beavo,et al.  Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. , 2000, Current opinion in cell biology.

[4]  J. Beavo,et al.  Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. P. Kuo,et al.  Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Cherry,et al.  Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect , 1999, The Journal of comparative neurology.

[7]  J. Palacios,et al.  Effects of rolipram on the elevated plus-maze test in rats: a preliminary study , 1999, Journal of psychopharmacology.

[8]  E. Kandel,et al.  Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Fastbom,et al.  A quantitative autoradiographic study of [ 3 H ]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits , 1999, Brain Research.

[10]  R. Duman,et al.  Chronic Antidepressant Administration Increases the Expression of cAMP-Specific Phosphodiesterase 4A and 4B Isoforms , 1999, The Journal of Neuroscience.

[11]  E. Kandel,et al.  Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Manuel Buttini,et al.  Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram , 1997, British journal of pharmacology.

[13]  A. Sawa,et al.  Rolipram, a phosphodiesterase-4-selective inhibitor, promotes the survival of cultured rat dopaminergic neurons. , 1997, Japanese journal of pharmacology.

[14]  K. Jarnagin,et al.  Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis. , 1997, Biochimica et biophysica acta.

[15]  R. Owens,et al.  Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells. , 1997, The Biochemical journal.

[16]  J. Palacios,et al.  Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study. , 1997, Brain research. Molecular brain research.

[17]  Y. Tano,et al.  Differential distribution of mRNA encoding cAMP-specific phosphodiesterase isoforms in the rat brain. , 1996, Brain research. Molecular brain research.

[18]  R. Davis,et al.  Physiology and biochemistry of Drosophila learning mutants. , 1996, Physiological reviews.

[19]  R J Heaslip,et al.  Emetic, central nervous system, and pulmonary activities of rolipram in the dog. , 1995, European journal of pharmacology.

[20]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[21]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[22]  P. Hulley,et al.  Brain distribution of four rat homologues of the drosophila dunce cAMP phosphodiesterase , 1995, Journal of neuroscience research.

[23]  A. Fontana,et al.  The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis , 1995, Nature Medicine.

[24]  H. Lübbert,et al.  Molecular cloning and functional expression in yeast of a human cAMP‐specific phosphodiesterase subtype (PDE IV‐C) , 1995, FEBS letters.

[25]  Y. Itoyama,et al.  Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. , 1995, European journal of pharmacology.

[26]  L. Rodgers,et al.  Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases. , 1994, Gene.

[27]  H. Lübbert,et al.  Expression and regulation of human and rat phosphodiesterase type IV isogenes , 1994, FEBS letters.

[28]  E. Lalli,et al.  Signal transduction and gene regulation: the nuclear response to cAMP. , 1994, The Journal of biological chemistry.

[29]  K. Kogure,et al.  Mapping of second messenger and rolipram receptors in mammalian brain , 1992, Brain Research Bulletin.

[30]  D. Koshland,et al.  Identification of cyclic AMP as the response regulator for neurosecretory potentiation: a memory model system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Y. Zhong,et al.  Altered synaptic plasticity in Drosophila memory mutants with a defective cyclic AMP cascade. , 1991, Science.

[32]  P. Mcgeer,et al.  Anti-inflammatory drugs and Alzheimer disease , 1990, The Lancet.

[33]  H. G. Baumgarten,et al.  Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram , 1989, Brain Research.

[34]  N. Geyer,et al.  Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine , 1989, Pharmacopsychiatry.

[35]  R. Davis,et al.  Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Bertolino,et al.  Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. , 1988, International clinical psychopharmacology.

[37]  R. Aasland,et al.  Optimal conditions for hybridization with oligonucleotides: a study with myc-oncogene DNA probes. , 1988, Analytical biochemistry.

[38]  N. Strominger,et al.  Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides. , 1988, Journal of neurophysiology.

[39]  O. E. Millhouse.  Granule cells of the olfactory tubercle and the question of the islands of calleja , 1987, The Journal of comparative neurology.

[40]  H. Wachtel,et al.  Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors , 1986, Neuropharmacology.

[41]  M. Brezinski,et al.  Stereospecific binding of the antidepressant rolipram to brain protein structures. , 1986, European journal of pharmacology.

[42]  I. Mitchell,et al.  A semi-quantitative atlas of 5-hydroxytryptamine-1 receptors in the primate brain , 1986, Neuroscience.

[43]  G. Wooten,et al.  Regional tritium quenching in quantitative autoradiography of the central nervous system , 1985, Brain Research.

[44]  B. Pflug,et al.  Results of a Phase II Study of the Antidepressant Effect of Rolipram , 1984, Pharmacopsychiatry.

[45]  L. Heimer,et al.  Cell configurations in the olfactory tubercle of the rat , 1984, The Journal of comparative neurology.

[46]  H. Schneider.  Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. , 1984, Biochemical pharmacology.

[47]  W. Cowan,et al.  A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) , 1984, The Journal of comparative neurology.

[48]  H. Wachtel,et al.  Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors , 1983, Neuropharmacology.

[49]  E. Kandel,et al.  Molecular biology of learning: modulation of transmitter release. , 1982, Science.

[50]  Y. Jan,et al.  dunce, a mutant of Drosophila deficient in learning. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Andrew,et al.  ESSENTIALS OF NEUROLOGY , 1972 .

[52]  M. M. Appleman,et al.  Multiple cyclic nucleotide phosphodiesterase activities from rat brain. , 1971, Biochemistry.

[53]  S. Udenfriend.  B. TYROSINE HYDROXYLASE , 1966 .

[54]  M. Karnovsky,et al.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[55]  H. L. Borison,et al.  Physiology and pharmacology of vomiting. , 1953, Pharmacological reviews.

[56]  M. Houslay,et al.  The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions. , 1998, Advances in pharmacology.

[57]  R. Horowski,et al.  Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports , 1985 .

[58]  Ronald L. Davis,et al.  Defect in cyclic AMP phosphodiesterase due to the dunce mutation of learning in Drosophila melanogaster , 1981, Nature.